




版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
內科學急性腎衰竭顧勇ARF1.Definitionandconcept2.Pathogenesis3.Pathologyandpathophysiology4.Acutetubularnecrosis5.SpecialtypeofARF6.HandlingofARFDefinitionofARFSyndromeQuickdeclineofGFRAseriesofclinicalmanifestationAccumulationofnitrogen-containingtastesIncidenceofARFCommonhospitalization:5%ICU:>30%;74:243FeaturesofARFKidney:completerestorationoffunctionHighincidenceofcomplicationHighmorbidity&mortalityOtherorgansdamageClassificationofARFPrerenal:Hypoperfusion,functionality:55%-60%Renal:35%-40%Postrenal:urinarytract:5%CausesofprerenalARFLowvolume:bleeding,lostfromG-I,kidney,skin,thirdspaceLowcardiacoutput:myocardium,valve,Systemicvasodilatation:medicine,infection,allergy,liverfailureRenalarterialsystole:shock,medicine,liverfailureRenalARFRenalgreatvesselsGlomeruleAcutetubularnecrosis:ischemia/poisoningTubulesandinterstitiumPostrenalARF
Position:UreterbladderneckAnteriorurethraCause:Stone,coagulatedblood,Crystal,edema,deligationTumor,fibrosis,stenosis,prostateglandetc.ATNPathologyPathophysiologyCourseofdiseaseDiagnosisanddifferentialdiagnosisComplicationDeclineofGFRinARFAbnormalrenalhemodynamicsTubularimpairment:obstruction,backflowage,multi-organinvolvedNoperipheralcelldamageandinflammationRenaleffectiveperfusionIncreaseGFR:expansionofafferentarterioleofglomerulus/increasedkfUremicpericarditisSurvivalrateNephrologist,UrolandRadiol:WorkhandinhandNecrosis&ApoptosisinARFapoptoticbody→phagocytosisBackflow:ImpairedintegrityofepithelialcellsNormalfreethyroxinePosition:IncidenceofARFQuickdeclineofGFRDependon:differentsite,toxinconcentration,timeFactorsinvolvedinrenalhemodynamicsEndothelin:increasingreceptorblockingEDNO:decreasingOthers:PlateletActivatingFactor(PAF)AdenosineMedullaedemaTubuloglomerularfeedback:TGFTubularimpairmentObstruction:CaducousepithelialcellsandcomponentsCastBackflow:ImpairedintegrityofepithelialcellsAccordingtohistology:tubularcellsfalloffandnecrosis,castMetabolicchangeaftertubularcelldamageDecreasedATPCellularswellingIncreasedintracellularcalciumIntracellularacidosisActivationofphosphatidaseActivationofproteaseOxidativestressConsequenceofdamagedtubularcellsIntactSublethalDeath:Apoptosis/necrosisDependon:differentsite,toxinconcentration,timeNecrosis&ApoptosisinARFNecrosis:cellularswelling,chondriosomechangeDestroymembranousIntegrityReleaseproteinlysaseperipheralcelldamage/inflammationApoptosis:Activeenergyconsumptionprocesscellnucleusshrinkage→smallDNAfragmentcellmembrane:blebbingbutintegrityapoptoticbody→phagocytosisNoperipheralcelldamageandinflammationDependonseverityofimpairmentRepair,RegenerationandRecoveryRecoveryofSublethalcellsScavengenecroticcellsandintracavitarycastsRegenerationofepithelialcells:replacenecroticandcaducouscellsTubularepithelialcellsintegrityandfunctionrestorationCourseofATNInitiation:noparenchymaimpairmentMaintenance:parenchymaimpairment:1-2weeks,maybe11monthsRecoveryPerspectivestudy:notprovedQuickdeclineofGFRAnti-ICAM-1EndothelinreceptorantagonistDependon:differentsite,toxinconcentration,timeRecoveryofSublethalcellsClassificationofARFWoundinfectionsPeritonealdialysisMyocardialinfarctionPostrenalARFVolumecontrol/toxincleaningcellmembrane:blebbingbutintegrityActivationofphosphatidaseFactorsinvolvedinrenalhemodynamicsDiagnosisanddifferentialdiagnosisofATNDiagnosis:medicalhistory,physicalexamination,UrineAnalysis,bloodtestOtherexaminationspastmedicalhistory,drughistoryDifferentialdiagnosis:AcuteorChronicClassificationCausesSpecialtypeofARFTumorRenaltransplantationPregnancyLungdiseasesOperationonvesselsofheartLiverdiseasesNephroticSyndromeDrugsWhykidneyeasytobedamagedbydrugs?Largevolumeofbloodflow:25-30%heartstrokevolumeActivemetabolismLargestendothelialcellsurfaceRichenzymaticsystemTranscellulartransportConcentrationfunctionMuchoxygenconsumption,littleoxygensupply(medulla)ComplicationofARF(1)MetabolicHyperkalemiaMetabolicacidosisHyponatremiaHyponatremiaHyperphosphatemiaHypermagnesemiaHyperuricemiaCardiovascularPulmonaryedemaArrhythmiasPericarditisPericardialeffusionHypertensionMyocardialinfarctionPulmonaryembolismPneumonitisGastrointestinalNauseaVomitingMalnutritionGastritisGastrointestinalulcersGastrointestinalbleedingStomatitisorgingivitisParotitisorpancreatitisComplicationofARF(2)NeurologicNeuromuscularirritabilityAsterxisSeizuresMentalstatuschangesSomenolenceComaHematologicAnemiaBleedingInfectiousPneumoniaWoundinfectionsIVinfectionsSepticemiaUrinarytractinfectionOtherHiccupsDecreasedinsulincatabolismMildinsulinresistanceElevatedPTHReduced1,25-dihydroxy-and25-hydroxycitaminDLowtotalT3/T4NormalfreethyroxineHandlingofARF(1)PrerenalRenaleffectiveperfusionFluidsupplement:Wholeblood,plasma,crystalfluidHeart:volumeload,arrhythmiaCirrhosisOthersHandlingofARF(2)Renal:Prevention:Prerenalfactors:volume,cardio-respiratoryfunctionUseofdrugsEspeciallyVasoactiveagentDiureticOthersNecrosis&ApoptosisinARFIncreasethevolumeEndothelinreceptorantagonistClassificationofARFVasoactiveagentDifferentialdiagnosis:AcuteorChronicMyocardialinfarctionEDNO:decreasingcellnucleusshrinkage→smallDNAfragmentRepair,RegenerationandRecoveryLargestendothelialcellsurfaceAnti-ICAM-1Obstruction:FactorsinvolvedinrenalhemodynamicsIncidenceofARFDopamine1-3ug/kg/minIncreaseRPFandGFRPerspectivestudy:notprovedArhythmia/myocardialischemiaANPIncreaseGFR:expansionofafferentarterioleofglomerulus/increasedkfInhibitsodiumtransport,decreaseoxygenconsumptionExperimentsshowedeffectiveNotclinicallyconfirmedDiureticLargedoseDecreasevolumeloadMortalityanddialysisrateunchangedMannitol:NoclinicalevidenceIncreasethevolumeLowsodium(shift)OthersGrowthfactor:Insulin-LikeG-FEndothelinreceptorantagonistRGDpolypeptide:inhibittubularobstructionATPsupplementScavengeROSLeukocyteadhensioninhibiting:Anti-CD18Anti-ICAM-1Anti-P-selectinONRESEARCHNOWSpecialtreatmentofARF(notATN)CorticosteroidImmunosuppressiveagentPlasmapheresisAntiplateletBloodpressurecontrolComplicationtreatmentMetabolism:water-electrolyte,acid-basebalanceNutritionAnaemiaDialysisQuestions:Prognosis?Style?Dosage?Indication?DialysisPeritonealdialysisAcuteintermittenthemodialysisChroniccontinuoushemofiltration/hemodialysisCrystal,edema,deligationCourseofATNDependonseverityofimpairmentSpecialtreatmentofARF(notATN)WoundinfectionsConsequenceofdamagedtubularcellsCausesofprerenalARFapoptoticbody→phagocytosisTubularimpairmentCardiovascularfunctionunstableEndothelinreceptorantagonistAnti-ICAM-1Principle:TorelieveobstructionassoonaspossibleAccumulationofnitrogen-containingtastesHyperphosphatemiaDialysisAbsoluteIndicationsOliguria,urinaryvolume<500ml/dAnuria,>12hBUN>30mmol,Scr>1000μmol/LPneumonedema,noresponsetodiureticUremicencephalopathyUremicpericarditisIndicationo
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年租賃合同主體變更的具體規定
- 2025電視臺廣告合作合同模板
- 2025深圳室內裝修合同
- 2025沒有合同被辭退應該如何計算補償
- 關于房屋買賣合同
- 2025年簽訂“租賃合同”應注意哪些事項綜合指南
- 藥材買賣合同范文買賣
- 會議場所租賃合同樣本2025
- 技能培訓專題飛機場案例分析2
- 叉車司機的安全理論培訓
- 小學生預防傳染病主題班會
- 第六章 證據規則
- 數學建模數學實驗插值及案例
- 青海利亞達化工有限公司年產6000噸高純硼酸升級改造項目環評報告
- 35kv變電站土建施工方案
- 五年級下冊綜合實踐活動教案-有趣的拉線偶人 全國通用
- 人教版四年級數學下冊《營養午餐》評課稿
- 第六屆全國物流設計大賽一等獎作品
- LY/T 3302-2022人造板生產木粉塵燃爆防控技術規范
- 高考與四級英語的差距詞匯
- 水土保持工程質量評定規程sl3362006
評論
0/150
提交評論